Bristol-Myers Squibb (BMY)

See the following -

Can Doctors Teach The Body To Cure Cancer?

Jacoba Urist | The Atlantic | July 28, 2014

Increasingly, doctors are using their patients' own immune systems as valuable weapons against the disease...

Read More »

Expensive Drugs Forcing Cancer Doctors To Weigh Price

Robert Langreth | Bloomberg | May 31, 2014

...With new cancer drugs priced as high as $10,000 a month and more, and insurers tightening payment rules, patients who thought they were well covered increasingly find themselves having to make life-altering decisions about what they can afford. 

Read More »

Merck To Bristol-Myers Face Threats On India Patents (Correct)

Ketaki Gokhale | Bloomberg Businessweek | January 28, 2014

Pharmaceutical companies from Merck & Co. (MRK:US) to Bristol-Myers Squibb Co. (BMY:US) face fresh threats to protecting their patents in India as a government-appointed panel prepares to evaluate more drugs for local makers to copy.  The panel is looking beyond the cancer treatments it studied last year to areas such as HIV and diabetes, according to two people with knowledge of the matter, who asked not to be identified because the discussions are private.

Read More »

Pfizer Shares Software For Biotech Drug Research With Pharma Rivals

Ryan McBride | FierceBiotechIT | June 24, 2013

Pfizer ($PFE) has led the way in an effort to share software and standards for managing data on complex molecules, providing the tech know-how on a precompetitive basis to competitors such as GlaxoSmithKline ($GSK), Roche ($RHHBY) and Bristol-Myers Squibb ($BMY). Read More »

Pharmaceutical CEO Says His Cancer-Fighting Drugs Aren't For Poor People

Vivian Giang | PolicyMic | January 27, 2014

Big pharmaceutical companies constantly compete with one another to come up with the next "superstar" life-saving drug. But when the cure becomes a means of making money rather than a way to save lives, maybe they should refocus their mission statements.

Read More »